Cardiopulmonary Resuscitation in Cases of Sudden Cardiac Arrest

October 17, 2023 updated by: Egymedicalpedia

The Success Rate of Cardiopulmonary Resuscitation in Sudden Cardiac Arrest

Determination the success rate of CPR on adults in Emergency room and predicting the factors that makes CPR is successful.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Cardiac arrest is a medical emergency that requires immediate cardiopulmonary resuscitation (CPR). Return of spontaneous circulation (ROSC) is a core outcome element of cardiopulmonary resuscitation (CPR) both in out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest and has been considered a standard in the evaluation of successful resuscitation.

ROSC was defined as a clinical assessment that shows signs of life comprising of a palpable pulse for at least 20 minutes or generating a blood pressure, the duration of ROSC is key element not only to the efficacy of the chain of survival but also to assess the success of resuscitation in emergency medical services (EMSs).

Worldwide CPR outcomes vary due to differences in the circumstances of cardiac arrest, availability of equipment, and performance of the CPR team. The influencing factors of CPR outcome at the emergency room (ER) are patient characteristics, early detection, immediate CPR, initial shockable rhythm, duration of CPR of less than 10 minutes and advanced cardiac life support.

In Egypt, There has been scarce studies regarding CPR and studies that measure the success rate of CPR and factors determining its success. This study aims to assess the success rate of CPR in Emergency room and factors predicting successful CPR on adults.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Cairo, Egypt
        • Alhusein Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Resuscitated at the ER in Al Hussein University Hospital.
  • Patients Have experienced cardiac arrest.

Exclusion Criteria:

  • Patient arresting and receiving CPR inside hospital's other departments.
  • Signs of sure death.
  • Patient with Multiple Organ Failure Syndrome (M.O.F syndrome

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CPR asseement
determine the success rate of CPR in Emergency room and factors predicting successful CPR
CPR in cardiac arrest patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CPR Success Rate
Time Frame: From base line to 20 minutes.
The rate of CPR defined by the Return of spontaneous circulation(ROSC) rate, Survival to hospital admission rate and survival to hospital discharge rate.
From base line to 20 minutes.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
predictors of Return of spontaneous circulation(ROSC)
Time Frame: from base line to 8 hoiurs
ROSC was defined as a clinical assessment that shows signs of life comprising of a palpable pulse for at least 20 minutes or generating a blood pressure, the duration of ROSC is key element not only to the efficacy of the chain of survival but also to assess the success of resuscitation in emergency medical services
from base line to 8 hoiurs

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Ahmed Mohamed Abdelgaleel, Professor, Al-Azhar University, Faculty of medicine for boys

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2023

Primary Completion (Actual)

June 15, 2023

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

January 28, 2023

First Submitted That Met QC Criteria

February 6, 2023

First Posted (Actual)

February 8, 2023

Study Record Updates

Last Update Posted (Actual)

October 19, 2023

Last Update Submitted That Met QC Criteria

October 17, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Arrest

Clinical Trials on CPR

3
Subscribe